Multiparametric Magnetic Resonance Imaging (MRI) in Medullary Sponge Kidney
Launched by HOSPICES CIVILS DE LYON · Dec 27, 2022
Trial Information
Current as of June 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • medullary sponge kidney attending medical consultation
- • Patients with glomerular filtration rate \> 60 mL/min/1.73m2 without kidney stone
- • consent signed
- • effective contraceptive method for women
- • affiliated to social insurance scheme
- Exclusion Criteria:
- • kidney transplant
- • polycystic kidney diseases
- • Chronic kidney disease (GFR \< 60 mL/min/1,73m² )
- • MRI contraindications (claustrophobia, pacemaker, cardioverter defibrillators implantable, mechanical heart valve non MRI-compatible)
- • Weight\> 130 kg
- • pregnancy
- • legal protection measure (guardianship, curatorship)
- • Deprived of liberty by a judicial or administrative decision
- • subject participating in another research that may interfere with the research and including an exclusion period still in progress at inclusion
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials